Zimmer Biomet
ZBH
#1280
Rank
C$24.05 B
Marketcap
C$121.36
Share price
0.73%
Change (1 day)
-21.09%
Change (1 year)
Categories

P/E ratio for Zimmer Biomet (ZBH)

P/E ratio as of February 2026 (TTM): 21.6

According to Zimmer Biomet's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 21.553. At the end of 2024 the company had a P/E ratio of 23.6.

P/E ratio history for Zimmer Biomet from 2002 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202423.6-3.41%
202324.5-78.45%
202211382.89%
202162.1-129.24%
2020-212-940.82%
201925.2
201712.1-80.7%
201662.8
201318.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Edwards Lifesciences
EW
33.3 54.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
46.9 117.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
42.3 96.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Dentsply Sirona
XRAY
-2.80-112.98%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.